1. Home
  2. LPCN vs GORO Comparison

LPCN vs GORO Comparison

Compare LPCN & GORO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LPCN
  • GORO
  • Stock Information
  • Founded
  • LPCN 1997
  • GORO 1998
  • Country
  • LPCN United States
  • GORO United States
  • Employees
  • LPCN N/A
  • GORO N/A
  • Industry
  • LPCN Biotechnology: Pharmaceutical Preparations
  • GORO Precious Metals
  • Sector
  • LPCN Health Care
  • GORO Basic Materials
  • Exchange
  • LPCN Nasdaq
  • GORO Nasdaq
  • Market Cap
  • LPCN 36.8M
  • GORO 40.2M
  • IPO Year
  • LPCN N/A
  • GORO N/A
  • Fundamental
  • Price
  • LPCN $5.46
  • GORO $0.51
  • Analyst Decision
  • LPCN Strong Buy
  • GORO Strong Buy
  • Analyst Count
  • LPCN 1
  • GORO 1
  • Target Price
  • LPCN $10.00
  • GORO $1.75
  • AVG Volume (30 Days)
  • LPCN 23.4K
  • GORO 482.1K
  • Earning Date
  • LPCN 11-06-2024
  • GORO 10-31-2024
  • Dividend Yield
  • LPCN N/A
  • GORO N/A
  • EPS Growth
  • LPCN N/A
  • GORO N/A
  • EPS
  • LPCN N/A
  • GORO N/A
  • Revenue
  • LPCN $4,800,930.00
  • GORO $81,177,000.00
  • Revenue This Year
  • LPCN N/A
  • GORO N/A
  • Revenue Next Year
  • LPCN N/A
  • GORO $48.90
  • P/E Ratio
  • LPCN N/A
  • GORO N/A
  • Revenue Growth
  • LPCN 8630.55
  • GORO N/A
  • 52 Week Low
  • LPCN $2.31
  • GORO $0.22
  • 52 Week High
  • LPCN $11.79
  • GORO $0.71
  • Technical
  • Relative Strength Index (RSI)
  • LPCN 61.75
  • GORO 74.50
  • Support Level
  • LPCN $4.89
  • GORO $0.40
  • Resistance Level
  • LPCN $5.85
  • GORO $0.48
  • Average True Range (ATR)
  • LPCN 0.38
  • GORO 0.04
  • MACD
  • LPCN 0.04
  • GORO 0.01
  • Stochastic Oscillator
  • LPCN 64.83
  • GORO 100.00

About LPCN Lipocine Inc.

Lipocine Inc is a clinical-stage biopharmaceutical company. It is focused on oral drug delivery technology for the development of pharmaceutical products focusing on metabolic and endocrine disorders. The company's product TLANDO is an oral testosterone replacement therapy ("TRT"). It also has other products in the pipeline such as LPCN 1144, LPCN 1148, and LPCN 1107. The Company has single reportable segment being, research and development for the delivery of drugs using its proprietary delivery technology.

About GORO Gold Resource Corporation

Gold Resource Corp is a gold and silver producer, developer, and explorer with operations in Oaxaca, Mexico, and Nevada, USA. It targets low capital expenditure projects with the potential for generating high returns on capital. The company's two pipeline projects are; Don David Gold at Oaxaca, Mexico, and Back Forty at Michigan, United States of America.

Share on Social Networks: